Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Attention Deficit Hyperactivity Disorder
IRCT20160530028182N8Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of coenzyme q10 in attention deficit hyperactivity disorder (ADHD), sponsored by Kurdistan University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
coenzyme q10
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20160530028182N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160530028182N8.